Riskpilot← Back to searchSign inGet full accessAlfimed AB
ABActiveOrg 5590021035Karbingatan 38Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20151 employees
Revenue 2024
SEK 5,5M
+86% vs 2023
EBITDA margin
-0.3%
+96% vs 2023
Equity ratio
39.4%
Financial strength
Net profit 2024
SEK -16K
+95% vs 2023
| Revenue | SEK 5,5M | +86% |
| EBITDA | SEK -18K | +96% |
| Net profit | SEK -16K | +95% |
| Total assets | SEK 1,7M | +113% |
| Equity | SEK 685K | +572% |
| Employees | 1 | — |
Legal name
Alfimed AB
Org number
5590021035
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
29 januari 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva import, marknadsföring och försäljning av ortopediska rehabiliteringsprodukter, äga och förvalta fast lös egendom samt därmed förenlig verksamhet.
Address
Karbingatan 38
Email
info@orteo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 2 966 | 3 385 | 2 579 | 3 095 | 3 555 | 2 967 | 5 523 |
| Staff expenses | — | — | — | — | — | — | — | −1 046 | — | — |
| EBITDA | −110 | −428 | −330 | 511 | 608 | 96 | 301 | 98 | −462 | −18 |
| Depreciation & amort. | −0 | −0 | −23 | −0 | −0 | −0 | −0 | — | −0 | −0 |
| EBIT | −110 | −428 | −353 | 511 | 608 | 96 | 301 | 98 | −462 | −18 |
| Net financials | — | — | −9 | −6 | −1 | −1 | −2 | −1 | −1 | 1 |
| Profit before tax | −110 | −428 | −362 | 505 | 547 | 65 | 219 | 97 | −293 | −16 |
| Tax | −0 | −0 | −0 | −0 | −45 | −21 | −55 | −26 | −0 | −0 |
| Net profit | −110 | −428 | −362 | 505 | 502 | 44 | 164 | 71 | −293 | −16 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 959 | 811 | 950 | 985 | 1 305 | 970 | 1 310 | 1 207 | 815 | 1 738 |
| Equity | 840 | 412 | 51 | 555 | 655 | 460 | 624 | 544 | 102 | 685 |
| Long-term debt | 0 | 0 | 107 | 0 | 0 | 0 | 0 | — | 0 | 0 |
| Short-term debt | 119 | 399 | 792 | 430 | 589 | 421 | 517 | 493 | 713 | 1 052 |
| Total debt | 119 | 399 | 899 | 430 | 589 | 421 | 517 | 493 | 713 | 1 052 |
EBITDA margin
-0.3%
This company
15.8%
Market median
-102% vs market
20152024
Equity ratio
39.4%
This company
38.2%
Market median
+3% vs market
20152024
Return on equity
-2.3%
This company
18.4%
Market median
-113% vs market
20152024
Net profit margin
-0.3%
This company
8.1%
Market median
-104% vs market
20152024
Asset turnover
3.18×
This company
1.12×
Market median
+184% vs market
20152024
Debt / equity
1.54×
This company
0.62×
Market median
-148% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TE Chief Auditor | Chief Auditor | 2023 | — | — |
EM Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
VJ Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alfimed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tord Erik Sassler | Chief Auditor | 0 companies |
| Erik Mikael Eriksson | Chief Executive Officer | 0 companies |
| Vicky Johansson | Chief Auditor | 0 companies |
| Jens Peter Allard | Chairman | 0 companies |
| Geir Finnerud | Board of Directors | 0 companies |